Works matching IS 02724391 AND DT 2005 AND VI 65 AND IP 3
1
- Drug Development Research, 2005, v. 65, n. 3, p. 156, doi. 10.1002/ddr.20019
- Miao‐kun Sun;
- Daniel L. Alkon
- Article
2
- Drug Development Research, 2005, v. 65, n. 3, p. 170, doi. 10.1002/ddr.20020
- Article
3
- Drug Development Research, 2005, v. 65, n. 3, p. 179, doi. 10.1002/ddr.20021
- Witte J.G. Hoogendijk;
- Ritsaert Lieverse;
- Aartjan T.F. Beekman
- Article
4
- Drug Development Research, 2005, v. 65, n. 3, p. 147, doi. 10.1002/ddr.20018
- Gabriel Schreiber;
- Sofia Avissar
- Article
5
- Drug Development Research, 2005, v. 65, n. 3, p. 141, doi. 10.1002/ddr.20017
- Franck Chenu;
- Eric Dailly;
- Michel Bourin
- Article
6
- Drug Development Research, 2005, v. 65, n. 3, p. 133, doi. 10.1002/ddr.20016
- Michel Bourin;
- Brid Aine Nic Dhonnchadha
- Article
7
- Drug Development Research, 2005, v. 65, n. 3, p. 126, doi. 10.1002/ddr.20015
- Article
8
- Drug Development Research, 2005, v. 65, n. 3, p. 119, doi. 10.1002/ddr.20014
- N. Zisapel;
- R. Tarrasch;
- M. Laudon
- Article
9
- Drug Development Research, 2005, v. 65, n. 3, p. 97, doi. 10.1002/ddr.20013
- Article
10
- Drug Development Research, 2005, v. 65, n. 3, p. 93, doi. 10.1002/ddr.20012
- David Gurwitz;
- Abraham Weizman
- Article